LifeSteps Financial’s ABVC BioPharma ABVC Stock Holding History

LifeSteps Financial’s Portfolio ABVC Stock Details ABVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-300	Closed	-$474	–	116
2026 Q2	$474	Buy	+300	New	+$374	﹤0.01%	759

Other funds holding ABVC

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

LifeSteps Financial's ABVC Position: Q3 2026 in Review

LifeSteps Financial sold out of ABVC BioPharma (ABVC) in Q3 2026, closing a stake of 300 shares — an estimated $474 sold.

LifeSteps Financial first reported a position in ABVC in Q2 2026 and held it in 1 quarter. The position peaked at $474 in Q2 2026. 1 fund tracked by Wall St. Rank holds ABVC as of Q3 2026.

LifeSteps Financial reported no remaining ABVC BioPharma position as of Q3 2026 after selling out during the quarter.
LifeSteps Financial sold 300 ABVC BioPharma shares in Q3 2026, an estimated $474.
LifeSteps Financial first reported a position in ABVC BioPharma in Q2 2026 and held it in 1 quarter.
LifeSteps Financial's ABVC BioPharma position peaked at $474 in Q2 2026.
1 fund tracked by Wall St. Rank held ABVC BioPharma as of Q3 2026.

Based on LifeSteps Financial's 13F filing for Q3 2026, filed 15 Oct 2026.